Cephalosporin-associated biliary pseudolithiasis in children

A.E. Abaturov, N.Yu. Zavhorodnia

Abstract


The review presents current data about cephalosporin-associated biliary sludge and cholelithiasis formation mechanism. Risks factors of pseudolithiasis development in children, who received cephalosporins, are analyzed and systematized. Moreover, the study provides information about the prevalence of pseudolithiasis in different periods of childhood. Not only main ways of ceftriaxone-induced cholelithiasis clinical course, but also the most common complications of pseudolithiasis have been described. The report characterizes typical clinical symptoms and sonographic features of pseudolithiasis in children. Furthermore, the research considers main methods of treatment that allow to avoid unnecessary cholecystectomy in children. For writing the review, we used such databases, as Scopus, Web of Science, MedLine, PubMed, Google Scholar, CyberLeninka, RSCI.

Keywords


cephalosporins; biliary cholelithiasis; children; review

References


Acun C, Erdem LO, Sogut A, et al. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study. Ann Trop Paediatr. 2004;24:25-31. doi: 10.1179/027249304225013349.

Nayak A, Slivka A. Ceftriaxone-Induced Gallstones: Case Report and Literature Review. ACG Case Rep J. 2014;1(3):170-2. doi: 10.14309/crj.2014.40.

Alemayehu H, Desai AA, Thomas P, et al. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis. Pediatr Surg Int. 2014;30(3):323-6. doi: 10.1007/s00383-014-3477-y.

Arpacik M, Ceran C, Kaya T, et al. Effects of ceftriaxone sodium on in vitro gallbladder contractility in guinea pigs. J Surg Res. 2004;122(2):157-61. doi: 10.1016/j.jss.2004.05.020.

Baltimore RS, Gewitz M, Baddour LM, et al. Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association. Circulation. 2015;132(15):1487-515. doi: 10.1161/CIR.0000000000000298.

Becker CD, Fischer RA. Acute cholecystitis caused by ceftriaxone stones in an adult. Case Rep Med. 2009;2009:132452. doi: 10.1155/2009/132452.

Berry JD, Shefner JM, Conwit R, et al. Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One. 2013;8(4):e61177. doi: 10.1371/journal.pone.0061177.

Biner B, Oner N, Celtik C, et al. Ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound. 2006;34(5):217-22. doi: 10.1002/jcu.20228.

Bonnet JP, Abid L, Dabhar A, et al. Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children. Eur J Pediatr Surg. 2000;10(6):368-71. doi: 10.1055/s-2008-107239.

Bor O, Dinleyici EC, Kebapci M, et al. Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study. Pediatr Int. 2004;46(3):322-4. doi: 10.1111/j.1328-0867.2004.01884.x.

Ceran C, Oztoprak I, Cankorkmaz L, et al. Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients. Int J Antimicrob Agents. 2005;25(3):256-9. doi:10.1016/j.ijantimicag.2004.10.008.

Cohen R, Raymond J, Faye A, et al. Management of urinary tract infections in children. Recommendations of the Pediatric Infectious Diseases Group of the French Pediatrics Society and the French-Language Infectious Diseases Society. Arch Pediatr. 2015;22(6):665-71. doi: 10.1016/j.arcped.2015.03.016.

Cudkowicz ME, Titus S, Kearney M, et al. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13(11):1083-91. doi: 10.1016/S1474-4422(14)70222-4.

Famularo G, Polchi S, De Simone C. Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: A rare but potentially severe complication. Ann Ital Med Int. 1999;14(3):202-4. PMID: 10566187.

Fretzayas А, Liapi O, Papadopoulou A, Polyxeni N, Stamoulakatou A. Is Ceftriaxone-Induced Biliary Pseudolithiasis Influenced by UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms? Case Rep Med. 2011;2011:730250. doi: 10.1155/2011/730250.

Gökçe S, Yıldırım M, Erdoğan D. A retrospective review of children with gallstone: single-center experience from Central Anatolia. Turk J Gastroenterol. 2014 Feb;25(1):46-53. doi: 10.5152/tjg.2014.3907.

Hagiya H, Hasegawa K, Asano K, et al. Ceftriaxone-induced biliary sludge in a patient with uncontrolled diabetes. Intern Med. 2014;53(21):2549-50. doi: 10.2169/internalmedicine.53.3377.

Herek O, Pakdemirli E, Kocer N. Ceftriaxone-associated biliary pseudolithiasis in children. Eur Radiol. 2001;11:902. doi: 10.1007/s003300000647.

Hua CZ, Yu H, Zhuang JQ, et al. An analysis of 181 cases with blood stream infection caused by Streptococcus agalactiae in children from 2011 to 2015: a multi-center retrospective study]. Zhonghua Er Ke Za Zhi. 2016;54(8):577-81. doi: 10.3760/cma.j.issn.0578-1310.2016.08.004.

Kim Y.S, Kestell MF, Lee SP. Gall-bladder sludge: lessons from ceftriaxone. J of Gastroenterology and Hepatology. 1992;7(6):618-21. doi: 10.1111/j.1440-1746.1992.tb01496.x.

Kong M, Chen C. Risk factors leading to ceftriaxoneassociated biliary pseudolithiasis in children. Changgeng Yi Xue Za Zhi. 1996;19(1):50-4. PMID: 8935375.

Krzemień G, Książczyk T, Szmigielska A, et al. Ceftriaxone-associated acute gallbladder enlargement — an unexpected diagnosis in the child with urinary tract infection. Dev Period Med. 2015;19(2):182-5. PMID: 26384120.

Martin E, Fanconi S, Kälin P, et al. Ceftriaxone-bilirubin-albumin interactions in the neonate: an in vivo study. Eur J Pediatr. 1993;152(6):530-4. doi:10.1007/BF01955067.

Meng D, Cao Y, Fu J, et al. Sonographic assessment of ceftriaxone-associated pseudolithiasis in Chinese children. J Int Med Res. 2010;38(6):2004-10. doi: 10.1177/147323001003800614.

Mooney ML, Haidet K, Liu J, Ebraheim NA. Hematogenous Calcaneal Osteomyelitis in Children: A Systematic Review of the Literature. Foot Ankle Spec. 2017;10(1):63-8. doi: 10.1177/1938640016679704.

Murata S, Aomatsu T, Yoden A, Tamai H. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis. Pediatr Int. 2015;57(5):942-6. doi: 10.1111/ped.12625.

Neff LP, Mishra G, Fortunato JE, Laudadio J, Petty JK. Microlithiasis, endoscopic ultrasound, and children: not just little gallstones in little adults. J. Pediatr Surg. 2011;46(3):462-6. doi: 10.1016/j.jpedsurg.2010.09.007.

Ozturk A, Kaya M, Zeyrek D, et al. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children. Acta Radiol. 2005;46(1):112-6. PMID: 15841750.

Palanduz A, Yalcin I, Tonguc E, et al. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound. 2000;28(4):166-8. PMID:10751736.

Papadopoulou F, Efremidis S, Karyda S, et al. Incidence of ceftriaxone-associated gallbladder pseudolithiasis. Acta Paediatr. 1999;88(12):1352-5. doi: 10.1111/j.1651-2227.1999.tb01050.x.

Park HZ, Lee SP, Schy AL. Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology. 1991;100(6):1665-70. PMID: 2019372.

Rodríguez Rangel DA, Pinilla Orejarena AP, Bustacara Diaz M, et al. Gallstones in association with the use of ceftriaxone in children. An Pediatr (Barc). 2014;80(2):77-80. doi: 10.1016/j.anpedi.2013.04.001.

Schaad UB, Suter S, Gianella-Borradori A, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. New Engl J Med. 1990;322(3):141-7. doi: 10.1056/NEJM199001183220301.

Schaad UB, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet. 1988;2(8625):1411-13. doi: 10.1016/S0140-6736(88)90596-X.

Schaad UB, Tschappeler H, Lentze MJ. Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis. 1986;5(6):708-10. PMID: 3540889.

WHO. Second Meeting of the Subcommittee of the Expert Committee on the Selection and Use of Essential Medicines Geneva, 29 September to 3 October 2008. Available from: http://www.who.int/selection_medicines/committees/subcommittee/2/en/.

Serdaroglu F, Koca YS, Saltik F, et al. Gallstones in childhood: etiology, clinical features, and prognosis. Eur J Gastroenterol Hepatol. 2016;28(12):1468-72. doi: 10.1097/MEG.0000000000000726.

Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology. 1990;99(6):1772-8. PMID: 2227290.

Shima A, Suehiro T, Takii M, et al. Reversible Ceftriaxone-Induced Pseudolithiasis in an Adult Patient with Maintenance Hemodialysis. Case Rep Nephrol Dial. 2015;5(3):187-91. doi: 10.1159/000440680.

Oh TH, Lee YC, Yang HK. Ceftriaxone-Induced Gallstone. Clinical Ultrasound. 2016;1(2):111-4. doi: 10.18525/cu.2016.1.2.111.

Tuna Kirsaclioglu C, Çuhaci Çakir B, Bayram G, et al. Risk factors, complications and outcome of cholelithiasis in children: A retrospective, single-centre review. J Paediatr Child Health. 2016;52(10):944-9. doi: 10.1111/jpc.13235.

Ustyol L, Bulut MD, Agengin K, et al. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children. Hum Exp Toxicol. 2016;10. pii: 0960327116658108. doi: 10.1177/0960327116658108.

Van Reempts P, Van Overmeire B, Mahieu LM, Vanacker KJ. Clinical experience with ceftriaxone treatment in the neonate. Chemotherapy. 1995;41(4):316-22. PMID: 7555213.

Xia Y, Lambert KJ, Schteingart CD, Gu JJ, Hofmann AF. Concentrative biliary secretion of ceftriaxone. Inhibition of lipid secretion and precipitation of calcium ceftriaxone in bile. Gastroenterology. 1990;99(2):454-65. PMID: 2365194.

Yoon Young Choi, Yun Hwa Jung, Su Mun Choi, Chul Seung Lee, Daeyong Kim, Kyung Yul Hur. Gallbladder pseudolithiasis caused by ceftriaxone in young adult. J Korean Surg Soc. 2011;81(6):423-6. doi: 10.4174/jkss.2011.81.6.423.

Zaffiri L, Gardner J, Toledo-Pereyra LH. History of antibiotics. From salvarsan to cephalosporins. J Invest Surg. 2012;25(2):67-77. doi: 10.3109/08941939.2012.664099.

Zaki SA, Shanbag P. A Biliary pseudolithiasis secondary to ceftriaxone therapy. Indian J Pharmacol. 2010;42(3):193-4. doi: 10.4103/0253-7613.66847.




DOI: https://doi.org/10.22141/2224-0551.12.2.2017.99772

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru